Aster Capital Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-742
Closed -$13.3K – 1127
2026
Q2
$13.3K Buy
+742
New +$10.4K ﹤0.01% 642
2025
Q3
– Sell
-1,797
Closed -$22K – 1148
2025
Q2
$22K Buy
+1,797
New +$26.1K 0.01% 695
2024
Q4
– Sell
-605
Closed -$11K – 1293
2024
Q3
$11K Buy
+605
New +$14K ﹤0.01% 786

Other funds holding IART

Aster Capital Management's IART Position: Q3 2026 in Review

Aster Capital Management sold out of Integra LifeSciences (IART) in Q3 2026, closing a stake of 742 shares — an estimated $13.3K sold.

Aster Capital Management first reported a position in IART in Q3 2024 and held it in 3 quarters. The position peaked at $22K in Q2 2025. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Aster Capital Management reported no remaining Integra LifeSciences position as of Q3 2026 after selling out during the quarter.
  • Aster Capital Management sold 742 Integra LifeSciences shares in Q3 2026, an estimated $13.3K.
  • Aster Capital Management first reported a position in Integra LifeSciences in Q3 2024 and held it in 3 quarters.
  • Aster Capital Management's Integra LifeSciences position peaked at $22K in Q2 2025.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.